DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

DaShenLin Pharmaceutical Group Co., Ltd.

603233

CNE100002RG2

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
22.12 ^CNY	-3.24%		+1.56%	-11.16%

04-28	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-28	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

DaShenLin Pharmaceutical Group Co., Ltd. Announces Cash Dividend for the Year 2019, Payable on June 17, 2020

June 09, 2020

DaShenLin Pharmaceutical Group Co., Ltd. announced cash dividend of RMB 0.6 (taxes included) per A share for the year 2019, payable on June 17, 2020. Record date is June 16, 2020 and ex-dividend date is June 17, 2020.

Latest news about DaShenLin Pharmaceutical Group Co., Ltd.

DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-28	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-27	CI
Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares	03-18	MT
Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares	03-04	MT
DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023	01-22	CI
Dashenlin Pharmaceutical to Boost Stake in Local Pharmacy Chain to 66% For 30 Million Yuan	11-27	MT
DaShenLin Pharmaceutical Group Co., Ltd. agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million.	11-24	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Dashenlin Pharmaceutical Unit Acquires Land for 1.20 Billion Yuan; Shares Jump 4%	23-03-28	MT
DaShenLin Pharmaceutical Group Co., Ltd. announced that it expects to receive CNY 3.025 billion in funding	23-01-18	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online	22-06-22	MT
UBS Adjusts Dashenlin Pharmaceutical's Price Target to 40 Yuan From 73.5 Yuan, Keeps at Buy	22-05-06	MT
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-19	CI
DaShenLin Pharmaceutical Group Co., Ltd. cancelled the acquisition of 51% stake in Nantong Jianghai Pharmacy Chain Co., Ltd. from Zhenjiang New District Dingjun Enterprise Management Center (Limited Partnership) and Zhenjiang New District Dingjun Enterprise Management Center (Limited Partnership).	20-11-05	CI
Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-30	CI

Chart DaShenLin Pharmaceutical Group Co., Ltd.

Duration

Period

Chart DaShenLin Pharmaceutical Group Co., Ltd.

More charts

Company Profile

DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.

Sector

Drug Retailers

Calendar

2024-05-19 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for DaShenLin Pharmaceutical Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.12 CNY

Average target price

33.11 CNY

Spread / Average Target

+49.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-11.16%	3.49B
WALGREENS BOOTS ALLIANCE, INC.	-34.16%	14.83B
JD HEALTH INTERNATIONAL INC.	-24.55%	12.04B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-25.24%	6.52B
YIFENG PHARMACY CHAIN CO., LTD.	+14.96%	6.44B
MATSUKIYOCOCOKARA & CO.	-8.01%	6.15B
NAHDI MEDICAL COMPANY	-2.34%	4.64B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+60.00%	4.62B
CLICKS GROUP LIMITED	-8.10%	3.93B
WELCIA HOLDINGS CO., LTD.	-6.77%	3.05B

Other Drug Retailers